KRYSTAL BIOTECH INC. - COMMON STOCK

Krystal Biotech to Present at BofA Securities 2025 Health Care Conference

07 مايو 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Announces First Quarter 2025 Financial and Operating Results

06 مايو 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

28 أبريل 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Present at Upcoming Scientific Conferences

24 أبريل 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025

17 أبريل 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

07 أبريل 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

28 فبراير 2025 07:40:09 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference

26 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results

19 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

06 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer

14 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

18 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels

12 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

09 ديسمبر 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Present at Upcoming Investor Conferences

27 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Present at Stifel 2024 Healthcare Conference

12 نوفمبر 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference

06 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

04 نوفمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024

28 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference

13 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire